NCT01492088
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +15 more
- Locations
-
- Aurora, Colorado, United States
- Kansas City, Missouri, United States
- New York, United States
- Houston, Texas, United States
Clinical trial condition
Lymphoma, Large-Cell, Anaplastic
Explore clinical trials studying Lymphoma, Large-Cell, Anaplastic. Study availability and eligibility vary by location and protocol.
291 public trials
18 recruiting studies
Lymphoma, Large-Cell, Anaplastic trial results
NCT01979536
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma, Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma, +12 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center Downey, California, United States
NCT01588015
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +198 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT02168140
- Conditions
- Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin Lymphoma, +40 more
- Locations
-
- Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States
- Abramson Cancer Center Philadelphia, Pennsylvania, United States
NCT01606878
- Conditions
- Childhood Solid Neoplasm, Hemic and Lymphatic Diseases, Immune System Diseases, +19 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Parnassus San Francisco, California, United States
NCT02561273
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Enteropathy-Associated T-Cell Lymphoma, +21 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto, California, United States
- University of Colorado Cancer Center, Anschutz Cancer Pavilion Aurora, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
NCT01524926
- Conditions
- Granuloma, Granuloma, Plasma Cell, Hemic and Lymphatic Diseases, +27 more
- Locations
-
- Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
- U.Z. Gasthuisberg Leuven, Belgium
- Institut Bergonie Bordeaux, France
- Centre Georges-Francois-Leclerc Dijon, France
NCT00577798
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiac Toxicity, +55 more
- Locations
-
- University of Nebraska Medical Center, Eppley Cancer Center Omaha, Nebraska, United States
Completed
Venetoclax and Romidepsin in Treating Patients With Recurrent or Refractory Mature T-Cell Lymphoma
NCT03534180
- Conditions
- Anaplastic Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
NCT01035463
- Conditions
- Anaplastic Large Cell Lymphoma, ALK-negative, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
- Locations
-
- University of Kansas Hospital-Westwood Cancer Center Westwood, Kansas, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States